Pre-treatment pan-immune-inflammation value as a prognostic marker of pazopanib in soft tissue sarcoma
Background: Increasingly, more evidence has shown that inflammation stress and the tumor microenvironment pose a negative effect on targeted therapy. The neutrophil-to-lymphocyte ratio is considered to be a surrogate biomarker of inflammation and can predict pazopanib treatment effect in non-adipocy...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publishing
2024-10-01
|
| Serie: | Therapeutic Advances in Medical Oncology |
| Accesso online: | https://doi.org/10.1177/17588359241292255 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|